OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Urology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	140
CDH12-expressing cell population predicts patient response to therapy	123
Krause corpuscles act as genital vibration detectors	115
Exploratory results from the CheckMate 214 trial	108
Immune infiltration associated with outcomes	107
Semen quality recovery following COVID-19	83
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	72
Texture analysis for patient selection	68
Single-cell and spatial sequencing of kidney cancer	66
Human-relevant urothelial model provides insight into infection strategies and host response	64
Sexual recovery interventions following prostate cancer treatment	55
Time for women-centred gynaecology	52
RAL-P in infants: expert tips for success	51
High-dose chemotherapy for relapsed testicular germ cell tumours	51
Preclinical models of bladder cancer: BBN and beyond	50
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	50
Advancing the state of the art in congenital obstructive uropathy	50
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity	48
PARP inhibitors plus enzalutamide to treat mCRPC	47
Urine microbiota differ in bladder cancer	46
Considering urology in a planetary context	45
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery	45
A clinical guide to rare male sexual disorders	44
The potential of CAR T cell therapy for prostate cancer	44
Proteomic-based analysis of testicular interstitial fluid	42

A new text message-based platform for self-management of patients with IC/BPS	41
Prevalence of gender dysphoria in Japan	41
Microfluidic sperm selection	41
FOXA2–KIT-driven lineage plasticity in NEPC	41
Understanding recurrence in chromophobe RCC	41
Ibrexafungerp to treat acute vulvovaginal candidiasis	39
Evolution of the World Health Organization semen analysis manual: where are we?	39
Madrid plays host to a celebration of urology	37
Overcoming antibiotic resistance in complicated UTI	36
Reducing the stigma of academic mental health can save lives	36
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	34
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	34
Galectins as potential therapeutic targets in STIs in the female genital tract	33
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	33
Metaverse in surgery — origins and future potential	32
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	32
A non-invasive assay for UTUC diagnosis	32
Pembrolizumab + axitinib beyond first-line therapy for mRCC	31
Measuring and improving the cradle-to-grave environmental performance of urological procedures	31
Mirabegron safe and effective for NDO	31
Resolving the puzzle of same-sex sexual interactions	31
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	30
Incorporating palliative care principles to improve patient care and quality of life in urologic oncology	30
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	29
177Lu–PSMA-PET extends survival	29
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	29
Vaccination to prevent untreatable gonorrhoea	27
COVID can’t kill CopMich collaboration	27
The mechanism of action of neuromodulation in the treatment of overactive bladder	26
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	26
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	25
Personalized 3D models for prostate cancer surgery	25
Efficacy of the Revi system in treating urgency urinary incontinence	25
PEACEing together prostate cancer therapy	25
Effect of high glucose on E. coli	24
Molecular events in neuroendocrine prostate cancer development	24
Is it time to rethink the current patient-reported outcome measures?	23
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	23
Robots learning to imitate surgeons — challenges and possibilities	23
Prostate cancer in transgender women — challenges in research and clinical care	22
Sexual orientation, gender identity and COVID: a complicated picture	22
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	21
Secondary kidney stones — remove or leave?	21
A clinical overview of people living with HIV and genitourinary cancer care	21
Promising efficacy of UTI vaccines as an alternative to antibiotics	20
Successful mentorship for women in urology — a new era	20
The magic of MagSToNE	20
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	20
Women in urology: the past	20
Videourodynamics — role, benefits and optimal practice	20

AUA returns to its former glory in Chicago	20
Cribriform morphology affects mpMRI imaging	20
The placebo and nocebo effects in functional urology	19
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	19
Microultrasonography-guided prostate cancer biopsy	19
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	19
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	18
Metabolic response to immunotherapy in prostate cancer	18
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	18
Androgen receptor pathway inhibitor combination in prostate cancer	18
Long-term OS and safety data from IMvigor211	17
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	17
Management and cost of stent encrustation in pregnancy	16
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	16
The evolving treatment landscape of metastatic urothelial cancer	16
Turning up the heat: CTLA4 blockade in urothelial cancer	15
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	15
Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer	14
The future of patient-derived xenografts in prostate cancer research	14
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	14
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	14
Immune-based therapies in penile cancer	13
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	13
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	12
The value of women urologists — individual and institutional imperatives to address salary equity	11
The prognostic role of stroma in UTUC	11
Hypoxia-inducible factor 2 inhibitors show promise in advanced kidney cancer	10
The unclear role of PET–CT in localized radiorecurrent prostate cancer	10
Uncovering a link between COVID-19 and renal cell carcinoma	10
The shifting treatment paradigm of metastatic renal cell carcinoma	10
We all get erections — de-gendering sexual arousal dysfunction in the ICD	10
BAUSing back in Birmingham	9
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	9
Improved phenotypic classification of male infertility to promote discovery of genetic causes	9
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	9
Hallmark discoveries in the biology of Wilms tumour	9
Prostate cancer screening: a new way forward or another false start?	9
Understanding iGCA	8
Power up to investigate PrEP	8
Mitomycin C plus cytosine arabinoside for NMIBC	8
Effects of COVID-19 vaccine on semen parameters	8
Patient selection is key in IMbassador250	8
CMA mediates resistance to androgen inhibitors in prostate cancer	8
Men hold the balance of power	8
Tuft cells in prostate cancer	8
Microbiota manipulation to prevent oxalate kidney stone formation	7
Diagnosis of ccRCC	7
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	7
Salvage therapy for prostate cancer after radical prostatectomy	7
Metabolism, mitochondria and metastasis in kidney cancer	7
Human kidney stones: a natural record of universal biomineralization	7
Male infertility and somatic health — insights into lipid damage as a mechanistic link	7
Mellow yellow: BilR reduces bilirubin to urobilinogen	7
Spatiotemporal trends in human semen quality	6
MRI diagnosis and radical prostatectomy outcomes	6
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	6
Semen parameters across testicular cancer stages	6
Mechanisms of the Supra-T paradox	6
Rising Black voices in urology — the next generation	6
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	6
Immune dysfunction and reprogramming in RCC	6
Sperm activity affected by endometriosis	6
Genetic ancestry and racial differences in prostate tumours	5
Chlorination by-products in drinking water — association with bladder cancer risk	5
Stepping up to prevent bacterial vaginosis recurrence	5
Probiotics to treat chronic bacterial prostatitis	5
Clinical trial design for non-muscle-invasive bladder cancer	5
Toilet-based continuous health monitoring using urine	5
Practical considerations for prostate hypofractionation in the developing world	5
Advances in sliding clip renorrhaphy for partial nephrectomy	5
Prostate luminal progenitor cells: from mouse to human, from health to disease	5
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	5
Artificial intelligence in the management of prostate cancer	5
The ins and outs of penile erection	5
Syphilis on the rise — a need for alternative therapies and vaccines	5
Particulate matter leaves a bitter taste in testes	5
Influence of substance use on male reproductive health and offspring outcomes	5
Urology on a changing planet: links between climate change and urological disease	5